Auris Surgical’s ARES is first robot bronchoscope approved by FDA
Robots are making their way into just about everything and next generation of robots are going to be surgical robots that will help ease pressure on doctors. Auris Surgical, a technology startup in the Silicon Valley is working on one such breakthrough surgical robot called the ARES (Auris Robotic Endoscopy System), which has been approved by the U.S. Food and Drug Administration (FDA). The remote controlled ARES robot was approved by FDA as a bronchoscope in May to view and treat lung conditions.
ARES, which is a new way of diagnosing and treating patients, has been undergoing tests. Through the pilot study, ARES has been tested with humans with lesions in the bronchi or with suspicion of lung cancer. In the diagnostic test carried out on 15 patients, the robot was able to navigate the airways without adverse effects. In all the 9 patients diagnosed with cancer, ARES robot was able to obtain biopsy samples from eight patients.
Auris Surgical, led by co-founder of Intuitive Surgical, company behind the famous da Vinci robot, has not given out a word on when the ARES will be announced publicly. However, a recent patent application filed by Aruis suggests the company is working on endolumenal (or endoluminal) surgery robots – flexible robots that surgeons will be able to steer through the human mouth to understand condition of the throat, lungs and gastrointestinal system, of which ARES is a likely part.
More information on IEEESpectrum